Turner K K - OmicsDI

Show results for

Unknown (3246)
Transcriptomics (83)
Genomics (43)
Proteomics (33)
Metabolomics (9)
Other (2)
Methylation profiling (1)

Organisms

Homo sapiens (88)
Mus musculus (26)
Drosophila melanogaster (7)
Escherichia coli str. K-12 substr. MG1655 (4)
Escherichia coli (3)
Severe acute respiratory syndrome coronavirus 2 (3)
Enterococcus faecium (2)
Pseudomonas aeruginosa (2)
Geobacter metallireducens (1)
Vigna unguiculata (1)
Mytilus galloprovincialis (1)
Plasmodium knowlesi (1)
Arabidopsis suecica (1)
Shewanella oneidensis (1)
Thalassiosira pseudonana (1)
Daphnia magna (1)
Mus musculus domesticus (1)
Clostridium acetobutylicum (1)
Ovis aries (1)
Caenorhabditis elegans (1)
Escherichia coli K-12 (1)
Canis lupus familiaris (1)
Arabidopsis thaliana (1)
Bos taurus (1)
Macaca mulatta (1)
Rattus norvegicus (1)
Schizosaccharomyces pombe (1)
Sus scrofa domesticus (1)

Organisms

Homo sapiens (4)
Escherichia coli (2)
Mus musculus (1)

Repository

biostudies-arrayexpress (92)
pride (32)
EGA (21)
MetaboLights (9)
ENA (8)
geo (7)
GPMDB (1)
MassIVE (1)

Tissue

Cerebrospinal fluid (5)
Cell culture (4)
Epithelial cell (4)
Blood (3)
Blood plasma (3)
Lung (3)
Brain (2)
T cell (2)
Blood cell (1)
Carotid artery segment (1)
Carotid atherosclerotic plaque (1)
Cerebrospinal fluid secreting cell (1)
Early embryonic cell (1)
Embryo (1)
Embryonic stem cell (1)
Epithelial cell of prostate (1)
Kidney (1)
Macrophage (1)
Neutrophil (1)
Skeletal muscle (1)

Disease

Amyotrophic lateral sclerosis type 1 (2)
COVID-19 (2)
Perilobar nephrogenic rest (1)
Not Available (1)
Amyotrophic lateral sclerosis (1)
Aortic valve stenosis (1)
Atherosclerosis (1)
Brain cancer (1)
Encephalopathy (1)
Intracranial hypertension (1)
Lung adenocarcinoma (1)
Multiple sclerosis (1)
Narcolepsy (1)
Neurodevelopmental delay (1)
Normal pressure hydrocephalus (1)
Parkinson's disease (1)
Peripheral neuropathy (1)
Prostate adenocarcinoma (1)

Technology Type

Mass Spectrometry (32)
Shotgun proteomics (15)
Bottom-up proteomics (11)
Mass spectrometry (9)
Data-dependent acquisition (4)
Data-independent acquisition (3)
All-ion fragmentation (2)
DiaPASEF (2)
SWATH MS (2)
Illumina (various), Illumina (Various) (1)
Illumina HiSeq 2000 (1)
Illumina_450K, Illumina_HumanHT-12_V4, ILLUMINA, Illumina HiSeq 2000 (1)
Affinity proteomics (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Proteogenomics (1)
SRM/MRM (1)

Instrument Platform

NextSeq 550 (2)
Illumina NovaSeq 6000 (2)
Q Exactive (2)
Liquid Chromatography MS - alternating - reverse phase (2)
Illumina Genome Analyzer (1)
Axon- GenePix4000B (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
NextSeq 500 (1)
Instrument (1)
LTQ Orbitrap Velos (1)
Atmospheric Pressure Matrix Assisted Laser Desorption/Ionization orbitrap MS - Positive (1)
Gas Chromatography MS - (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse phase (1)
MS Imaging - Atmospheric Pressure Matrix Assisted Laser Desorption/Ionization orbitrap MS - Positive (1)
Ultra-High Performance Liquid Chromatography - Time Of Flight MS - Negative (UPLC-TOF MS(Negative)) (Waters) (1)
Ultra-High Performance Liquid Chromatography-Q Exactive Plus MS&MS/MS-Negative(UHPLC-MS&MS/MS(Negative))(Thermo Scientific) (1)

Publication Date

2010 (24)
2025 (12)
2023 (12)
2014 (11)
2013 (10)
2011 (8)
2015 (7)
2012 (7)
2019 (6)
2016 (6)
2022 (5)
2009 (5)
2008 (5)
2026 (4)
2024 (4)
2007 (4)
2021 (3)
2020 (3)
2017 (3)
2005 (1)
2018 (1)

CHEBI ID

CHEBI:10072 (3)
CHEBI:15793 (3)
CHEBI:16040 (3)
CHEBI:16196 (3)
CHEBI:16235 (3)
CHEBI:16335 (3)
CHEBI:16390 (3)
CHEBI:16449 (3)
CHEBI:16704 (3)
CHEBI:16708 (3)
CHEBI:16919 (3)
CHEBI:17084 (3)
CHEBI:17368 (3)
CHEBI:17568 (3)
CHEBI:17822 (3)
CHEBI:18211 (3)
CHEBI:18237 (3)
CHEBI:18261 (3)
CHEBI:18344 (3)
CHEBI:25017 (3)
CHEBI:26271 (3)
CHEBI:27432 (3)
CHEBI:28088 (3)
CHEBI:28792 (3)
CHEBI:28842 (3)
CHEBI:28875 (3)
CHEBI:30653 (3)
CHEBI:30763 (3)
CHEBI:30769 (3)
CHEBI:30915 (3)

Metabolite Name

Arachidic acid (2)
Azelaic acid (2)
Eicosenoic acid (2)
Genistein (2)
Hypoxanthine (2)
Myristic acid (2)
N-Undecanoylglycine (2)
Nervonic acid (2)
Oleic acid (2)
Palmitoleic acid (2)
Stearic acid (2)
Uracil (2)
(+)-12-(2-Cyclopenten-1-yl)-2-dodecanone (1)
(+)-2,7-Dideoxypancratistatin (1)
(+)-Piperitone/d-Piperitone (1)
(+)-Prosopinine (1)
(+)-trans-Carveol glucoside (1)
(+)TAN-67 (1)
(+/-)-(Z)-2-(5-Tetradecenyl)cyclobutanone (1)
(+/-)-2-Hydroxy-4-(methylthio)butanoic acid (1)
(+/-)-Dihydrofarnesol (1)
(+/-)-Pelletierine (1)
(+/-)11(12)-EET Ethanolamide (1)
(-)-Solenopsin A (1)
(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C (1)
(13R,14R)-7-Labdene-13,14,15-triol (1)
(13R,14R)-8-Labdene-13,14,15-triol (1)
(1S,2R,4S)-(-)-Bornyl acetate (1)
(1S,2S,4R,8S)-p-Menthane-1,2,8,9-tetrol 2-glucoside (1)
(2'S)-Deoxymyxol 2'-(2,4-di-O-methyl-alpha-L-fucoside) (1)

First Public Date

2015 (2)
2014 (2)
2013 (2)
2020 (1)
2018 (1)

Classification

bacteria (2)

Study type

Transcription profiling by array (51)
RNA-seq of coding RNA (15)
ChIP-seq (8)
Unknown experiment type (3)
Methylation profiling by high throughput sequencing (3)
Comparative genomic hybridization by array (2)
DNA-seq (2)
Methylation profiling by array (2)
RNA-seq of non coding RNA (2)
High-throughput sequencing (1)
Human - One-color microarray (1)
CLIP-seq (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2022 (381)
2023 (378)
2021 (362)
2024 (349)
2025 (309)
2020 (271)
2019 (191)
2018 (155)
2015 (145)
2017 (140)
2016 (120)
2014 (105)
2012 (85)
2013 (81)
2010 (64)
2011 (54)
2026 (52)
2009 (34)
2008 (21)
2007 (14)
2006 (7)
2005 (4)
2004 (3)
2003 (3)
2001 (3)
2002 (2)
2000 (2)
1999 (1)
1998 (1)
1987 (1)

Lab affiliation

Functional Proteomics, ICR (2)
95 Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, 31077, France (1)
Bioinformatics, TruDiagnostic, USA (1)
Brigham and Women's Hospital, Harvard Medical School (1)
CARF Proteomics and Small Molecule Mass Spectrometry, Queensland University of Technology (1)
Canary Center at Stanford for Cancer Early Detection Department of Radiology School of Medicine Stanford University (1)
Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48201, USA (1)
Columbia University Irving Medical Center, New York, NY, USA (1)
Dana-Farber Cancer Institute Harvard Medical School Broad Institute Howard Hughes Medical Institute (1)
Department of Cellular and Molecular Pharmacology University of California San Francisco (UCSF) (1)
Department of Cellular and Molecular Pharmacology, UCSF (1)
Department of Integrative and Structural Computational Biology, The Scripps Research Institute, La Jolla, CA (1)
Functional Proteomic, ICR (1)
Louise B. McGavock Professor Department of Cell and Developmental Biology Senior Associate Dean for Biomedical Research, Education and Training Vanderbilt University School of Medicine (1)
MRC Toxicology Unit, Gleeson Building, Tennis Court Road, University of Cambridge, CB2 1QR (1)
Medical University of Vienna Center of Physiology and Pharmacology Department of Vascular Biology and Thrombosis Research Schwarzspanierstraße 17/I A- 1090 Vienna, Austria (1)
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK and John Radcliffe Hospital, West Wing Level 6, Oxford, OX3 9DU, UK (1)
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. (1)
Nuffield Department of Clinical Neurosciences, University of Oxford, UK (1)
Professor, Department of Cellular and Molecular Pharmacology (1)
Proteomics Center, Erasmus MC, Rotterdam, the Netherlands (1)
Target Discovery Institute (1)
Thayer School of Engineering, Dartmouth College; Hanover, NH 03755, USA Department of Convergence Medicine, Korea University College of Medicine, Seoul, Republic of Korea Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea (1)
The Insitute of Cancer Research (1)
The Institute of Cancer Research (1)
U o Cambridge (1)
University Health Network, Division of Vascular Surgery, Toronto General Hospital Research Institute, Division of Biomedical Research; Department of Surgery, University of Toronto; Toronto, Canada (1)
University of Oxford Target Discovery Institute (1)
University of Oxford, NDM Research Building, Target Discovery Institute, Kessler Group. OXFORD (1)
Universitätsmedizin Greifswald Interfakultäres Institut für Genetik und Funktionelle Genomforschung Abteilung für Funktionelle Genomforschung Felix-Hausdorff-Straße 8 17487 Greifswald (1)

Previous page
1 / 342
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 342
Next page

Sort by:

Relevance

Page size

DNA microarrays of Turner Syndrome induced pluripotent stem cells

We have generated iPSCs from monosomy X (Turner Syndrome), trisomy 8 (Warkany Syndrome 2), trisomy 13 (Patau Syndrome) and partial trisomy 11;22 (Emanuel Syndrome), using either skin fibroblasts from affected individuals or amniocytes from antenatal diagnostic tests. These cell lines stably maintain...

ORGANISM(S): Homo sapiens

2011-10-03 | E-GEOD-32527 | biostudies-arrayexpress

Transcription profiling of lung carcinoma and brain glioblastoma cells were analalyzed, with microarrays run both for control and treatment with dichloroacetate reveals a mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis inhibits cancer growth

The unique metabolic profile of most cancers (aerobic glycolysis) might confer apoptosis-resistance and be therapeutically targeted. Compared to normal cells, several human cancers have high mitochondrial membrane potential and low expression of the K+ channel Kv1.5, both contributing to apoptosis-r...

ORGANISM(S): Homo sapiens

2008-06-14 | E-GEOD-6014 | biostudies-arrayexpress

Response of ethanologenic E coli strains LY180 and EMFR9 to furfural

The data explore the transcriptional response of strain LY180 and the furfural-resistant derivative EMFR9 to 0.5 g/L furfural LY180 and EMFR9 and differences in their expression profiles are described in Miller, E. N., L. R. Jarboe, L. P. Yomano, S. W. York, K. T. Shanmugam, and L. O. Ingram. 2009. ...

ORGANISM(S): Escherichia coli

2010-05-06 | E-GEOD-17786 | biostudies-arrayexpress

Deficient knowledge in adult Turner syndrome care as an incentive to found Turner centers in Germany.

Not available

S-EPMC6865863 | biostudies-literature

The contribution of dendritic Kv3 K+ channels to burst threshold in a sensory neuron.

Not available

S-EPMC6762436 | biostudies-literature

Response of ethanologenic E coli strains LY180 and EMFR9 to furfural

ORGANISM(S): Escherichia coli Escherichia coli str. K-12 substr. MG1655

2009-08-25 | GSE17786 | GEO

Expression profiles of (40,XX) and (39,XO) females

Gobal expression analysis in four somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice with the aim of identifying which genes are expressed from both X chromosomes as well as those genes deregulated in X chromosome monosomy. Keywords: Expression profiling by array For ea...

ORGANISM(S): Mus musculus

2010-04-07 | E-GEOD-13520 | biostudies-arrayexpress

Uncommon etiology of Cullen's sign and Grey Turner sign.

Not available

S-EPMC9249938 | biostudies-literature

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.

Not available

S-EPMC4501086 | biostudies-literature

Granzyme K mediates IL-23-dependent inflammation and keratinocyte proliferation in psoriasis.

Not available

S-EPMC11188347 | biostudies-literature